Platelet-derived Microvesicles Transfer Tissue Factor to Monocytes but Not to Neutrophils
Overview
Affiliations
Activated platelets are known to adhere to both blood monocytes and neutrophils, and this adhesion is mainly mediated by the surface exposure of the platelet granule protein CD62P. Platelets as well as platelet-derived microvesicles (PMV) have also been shown to contain and to transfer tissue factor (TF), the most important initiator of intravascular thrombin and fibrin formation, to monocytes. However, the role of neutrophils for gathering platelet-derived TF is controversial. Here we studied the interaction of PMV with monocytes and neutrophils using a whole blood system. Platelet-rich plasma (PRP) obtained from citrated human blood was incubated with collagen (5 microg/ml, 15 min) and the platelets were removed by centrifugation (5 min at 5000 x g). After incubating the PMV-containing plasma for further 30 min with a sediment of red and white bloods cells that had been obtained after PRP preparation, monocytes and neutrophils were analysed by flow cytometry for the surface exposure of the platelet-specific antigen CD42a and TF. Compared to a control with non-activated PRP, there was a significant increase in the number of both CD42a-positive monocytes and neutrophils. In contrast, there was no change in the number of TF-positive neutrophils, but a more than 2-fold increase in the number of TF-positive monocytes. The changes in CD42a on monocytes and neutrophils as well as the changes in TF on monocytes could be significantly reduced by an anti-CD62P antibody or by removal of PMV from the plasma samples. The data indicate that the transfer of TF to monocytes is not simply an CD62P-mediated adhesion of platelets or PMV to monocytes, but may involve other not yet identified mechanisms.
Extracellular Vesicles as Mediators in Atherosclerotic Cardiovascular Disease.
Zisser L, Binder C J Lipid Atheroscler. 2024; 13(3):232-261.
PMID: 39355407 PMC: 11439751. DOI: 10.12997/jla.2024.13.3.232.
Bioinspired cellular membrane-derived vesicles for mRNA delivery.
Xu X, Xu L, Wang J, Wen C, Xia J, Zhang Y Theranostics. 2024; 14(8):3246-3266.
PMID: 38855184 PMC: 11155408. DOI: 10.7150/thno.93755.
Cheng C Mol Pharm. 2024; 21(6):2625-2636.
PMID: 38771015 PMC: 11151200. DOI: 10.1021/acs.molpharmaceut.4c00185.
Microfluidic approaches for producing lipid-based nanoparticles for drug delivery applications.
Piunti C, Cimetta E Biophys Rev (Melville). 2024; 4(3):031304.
PMID: 38505779 PMC: 10903496. DOI: 10.1063/5.0150345.
Advances in extracellular vesicle functionalization strategies for tissue regeneration.
Zheng D, Ruan H, Chen W, Zhang Y, Cui W, Chen H Bioact Mater. 2023; 25:500-526.
PMID: 37056271 PMC: 10087114. DOI: 10.1016/j.bioactmat.2022.07.022.